CytoDyn Investor Relations Material
Latest events
AGM 2024
CytoDyn
Q3 2025
14 Apr, 2025
Q2 2025
14 Jan, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from CytoDyn Inc
Access all reports
CytoDyn Inc. is a biotechnology company focused on the development of innovative treatments for infectious diseases, cancer, and immune-related conditions. The company specializes in monoclonal antibody therapies and explores applications in virology, immunology, and oncology. The company is headquartered in Vancouver, Washington, and its shares are listed on the OTCQB.
Latest articles
)
Eli Lilly: The Pharma Giant Behind Mounjaro and Zepbound
Eli Lilly's journey from insulin pioneer to global pharma giant, leading innovation in diabetes, obesity, and the future of metabolic health.
30 Jun 2025
)
500 Years of Craft, One Family Legacy: Beretta Holding's Global Expansion
How Beretta Holding managed to transform from a 16th-century gun barrel producer into a global industrial group while preserving 500 years of legacy.
27 Jun 2025
)
Shuntaro Furukawa: The Sixth President of Nintendo
Shuntaro Furukawa, Nintendo's sixth president, went from a childhood fan to leading the company through global expansion and the launch of Switch 2.
23 Jun 2025
Ticker symbol
CYDY
Country
🇺🇸 United States